CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005317
NCT00005317N/ACompleted
CompareCT.gov

Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Jul 12, 2016

In Brief

An observational study for Lung Diseases and 3 related conditions. Completed.

Detailed Summary

To conduct cross-sectional and longitudinal studies of patients with idiopathic pulmonary fibrosis (IPF) and patients with progressive systemic sclerosis (PSS), with and without associated lung disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Pulmonary Fibrosis, Lung Diseases, Interstitial, Scleroderma, Systemic
Countries--
Collaborators--

Timeline

N/ACompletedFinished
198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartDec 1, 1986
Study CompletionNov 1, 1996
TodayJul 2, 2026
Posted 26.1 years ago